Tizanidine
Generic Name: Tizanidine
Uses & Medical Indications
Management of spasticity
Muscle spasticity (e.g., from multiple sclerosis or spinal cord injury)
Work Mechanism & Pharmacology
Patient Overview of Work Mechanism
Tizanidine works at the cellular level to correct underlying biochemical imbalances, reduce clinical symptoms, and support overall health.
Clinical Mechanism of Action (MoA)
Tizanidine exerts targeted therapeutic activity by interacting with specific cellular receptors, enzymatic pathways, or biological signaling cascades to relieve symptoms and restore physiological balance.
Dosage & Administration Guidelines
2 mg every 6 to 8 hours initially, titrate up to 8-24 mg/day
Safety and efficacy not established
Start low and titrate slowly
36 mg/day
Use with caution in CrCl < 25 mL/min; reduce dose
Avoid or use with extreme caution in hepatic impairment
Side Effects & Safety Warnings
Dry mouth, somnolence, asthenia, dizziness
Hepatotoxicity, hypotension, hallucinations
Concomitant use with ciprofloxacin or fluvoxamine
Hypotension risk, liver injury, withdrawal with abrupt discontinuation
Interactions (Drugs, Food & Alcohol)
CYP1A2 inhibitors (ciprofloxacin, fluvoxamine), other CNS depressants
Food alters pharmacokinetics differently for tablet vs capsule
Increases CNS depression
Pregnancy & Breastfeeding Safety
Use only if benefit justifies potential risk
Not recommended
Patient Counseling & Practical Advice
May cause drowsiness or dizziness. Do not abruptly stop taking. Be consistent regarding taking with or without food.
Skip the missed dose and resume normal schedule.
Blood pressure, liver function tests at baseline and periodically
When to Seek Urgent Medical Attention
Seek immediate emergency medical care (call emergency services or proceed to the nearest emergency department) if you experience signs of a life-threatening allergic reaction (anaphylaxis: facial, lip, tongue, or throat swelling causing airway obstruction), severe cutaneous blistering with skin peeling, sudden intense chest pain, or symptoms of overdose.
Content for Tizanidine was synthesized from standardized public health monographs, official pharmacopoeias, and health authorities:
- Central Drugs Standard Control Organization (CDSCO) — National List of Essential Medicines
- World Health Organization (WHO) — Model List of Essential Medicines
- Indian Pharmacopoeia Commission (IPC) — Indian Pharmacopoeia Drug Monographs
- National Health Service (NHS) — Medicines A to Z Clinical Guidelines
The information provided on this website is for educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition.